03.21.22
RoC Skincare has unveiled the Derm Correxion franchise, and will showcase the first product in the new line at the line at the American Academy of Dermatology (AAD) Annual Meeting in Boston later this week.
The franchise will debut with RoC Derm Correxion Fill + Treat Serum, a non-invasive wrinkle filling treatment that targets the appearance of stubborn lines instantly and over time using a patent-pending 3D approach that works deep within skin's surface, targeting all layers, according to the brand.
The formulation includes three forms of hyaluronic acid, retinol and Swertiamarin, an ingredient inspired by its use in the US military to help treat damaged skin, supports the rebuilding of epidermal layers that are lost as people age.
In clinical studies, 97% of users instantly had fine lines and wrinkles visibly plumped and filled, and within four weeks, 100% showed improvement in the look of hard-to-treat wrinkles, including crow's feet, laugh lines and 11 lines.
"As a leader in retinol for decades, RoC continues to research and innovate on this gold standard of anti-aging, pushing the boundaries to provide lasting skin health and beauty benefits," said Art Pellegrino, SVP of R&D at RoC Skincare. "With the launch of Derm Correxion, we are excited to leverage new data from our research on Retinol's increased efficacy when formulated with Hyaluronic Acid."
According to RoC, Derm Correxion is the culmination of a multi-year research and development program in partnership with an advisory board of dermatologists and plastic surgeons whose insights and understanding of patient needs and desires were leveraged to create topical, high-efficacy skincare solutions. The advisory board includes:
• Joshua Zeichner, MD, Board-Certified Dermatologist, New York, NY
• Anna Guanche, MD, FAAD, Board-Certified Dermatologist, Calabasas, CA
• Melissa K. Levin, MD, FAAD, Board-Certified Dermatologist, New York, NY
• Sarmela Sunder, MD, Double Board-Certified Facial Plastic Surgeon, Beverly Hills, CA
• Wendy Lee, MD, Professor of Clinical Ophthalmology & Dermatology specializing in oculofacial plastic and reconstructive surgery, Miami, FL
"We created this line as an affordable, accessible option for consumers to experience the instant benefits of a highly effective wrinkle-filling treatment. We are honored to have partnered with top skincare medical professionals in the field to bring our vision and our Brand's dermatologist-recommended heritage to life," said Fernando Acosta, CEO of RoC Skincare.
Consumers can now purchase RoC Derm Correxion Fill + Treat Serum at Walmart and on the RoC e-commerce site. The collection will roll out nationally with additional innovation at major food, drug and mass retailers by September 2022.
The franchise will debut with RoC Derm Correxion Fill + Treat Serum, a non-invasive wrinkle filling treatment that targets the appearance of stubborn lines instantly and over time using a patent-pending 3D approach that works deep within skin's surface, targeting all layers, according to the brand.
The formulation includes three forms of hyaluronic acid, retinol and Swertiamarin, an ingredient inspired by its use in the US military to help treat damaged skin, supports the rebuilding of epidermal layers that are lost as people age.
In clinical studies, 97% of users instantly had fine lines and wrinkles visibly plumped and filled, and within four weeks, 100% showed improvement in the look of hard-to-treat wrinkles, including crow's feet, laugh lines and 11 lines.
"As a leader in retinol for decades, RoC continues to research and innovate on this gold standard of anti-aging, pushing the boundaries to provide lasting skin health and beauty benefits," said Art Pellegrino, SVP of R&D at RoC Skincare. "With the launch of Derm Correxion, we are excited to leverage new data from our research on Retinol's increased efficacy when formulated with Hyaluronic Acid."
According to RoC, Derm Correxion is the culmination of a multi-year research and development program in partnership with an advisory board of dermatologists and plastic surgeons whose insights and understanding of patient needs and desires were leveraged to create topical, high-efficacy skincare solutions. The advisory board includes:
• Joshua Zeichner, MD, Board-Certified Dermatologist, New York, NY
• Anna Guanche, MD, FAAD, Board-Certified Dermatologist, Calabasas, CA
• Melissa K. Levin, MD, FAAD, Board-Certified Dermatologist, New York, NY
• Sarmela Sunder, MD, Double Board-Certified Facial Plastic Surgeon, Beverly Hills, CA
• Wendy Lee, MD, Professor of Clinical Ophthalmology & Dermatology specializing in oculofacial plastic and reconstructive surgery, Miami, FL
"We created this line as an affordable, accessible option for consumers to experience the instant benefits of a highly effective wrinkle-filling treatment. We are honored to have partnered with top skincare medical professionals in the field to bring our vision and our Brand's dermatologist-recommended heritage to life," said Fernando Acosta, CEO of RoC Skincare.
Consumers can now purchase RoC Derm Correxion Fill + Treat Serum at Walmart and on the RoC e-commerce site. The collection will roll out nationally with additional innovation at major food, drug and mass retailers by September 2022.